Significant MP calls for RBRC Strains (IMPC_001)
Total number of results: 742
Gene / Allele | Procedure | Parameter | Zygosity | Sex | Phenotype | P-value | Graph |
---|---|---|---|---|---|---|---|
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | heterozygote | abnormal brain morphology | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Adcyap1r1 Adcyap1r1tm1e.1(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | enlarged lymph nodes | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | heterozygote | enlarged thymus | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | enlarged heart | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Ppme1 Ppme1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Bone | homozygote | abnormal bone structure | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Wasf2 Wasf2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Penk Penktm1(KOMP)Mbp |
Gross Pathology and Tissue Collection | Testes | homozygote | absent testes | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | enlarged heart | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | enlarged lymph nodes | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Kif2c Kif2ctm1.1(KOMP)Vlcg |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Sec24d Sec24dem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Sec24d Sec24dem1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | enlarged kidney | 0.0 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | homozygote | abnormal stomach morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | small epididymis | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | abnormal lymph node morphology | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | abnormal testis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | heterozygote | abnormal brain morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | abnormal testis morphology | 0.0 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | heterozygote | abnormal brain morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Bone | homozygote | abnormal bone structure | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Nxn Nxntm1b(EUCOMM)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Hrh1 Hrh1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Agtr1a Agtr1aem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Ikzf4 Ikzf4em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Wasf2 Wasf2em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Lcmt1 Lcmt1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | hydrocephaly | 0.0 | ||
Rufy3 Rufy3tm1b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Eye with optic nerve | homozygote | abnormal eye morphology | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | heterozygote | abnormal thymus morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
D1Pas1 D1Pas1tm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Eye with optic nerve | homozygote | abnormal eye morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | abnormal heart morphology | 0.0 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | homozygote | abnormal thymus morphology | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | abnormal lymph node morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Agtr1a Agtr1aem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Spleen | heterozygote | small spleen | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Bone | homozygote | abnormal bone structure | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Edn2 Edn2tm1b(KOMP)Mbp |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Unc5c Unc5cem2(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | heterozygote | enlarged lymph nodes | 0.0 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | small testis | 0.0 | ||
Agtr1a Agtr1aem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Ftl2-ps Ftl2-psem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | enlarged heart | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | small testis | 0.0 | ||
Tecr Tecrem1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Hikeshi Hikeshiem1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Rufy3 Rufy3tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Wasf2 Wasf2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | enlarged lymph nodes | 0.0 | ||
Katna1 Katna1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | abnormal heart morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Izumo1r Izumo1rtm1b(KOMP)Wtsi |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Atp6v0a4 Atp6v0a4tm1(KOMP)Vlcg |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | abnormal heart morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | abnormal heart morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
D1Pas1 D1Pas1tm1(KOMP)Vlcg |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | enlarged heart | 0.0 | ||
Dctn2 Dctn2tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Pomc Pomcem1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | abnormal epididymis morphology | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Katna1 Katna1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | heterozygote | enlarged epididymis | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | hydrocephaly | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | abnormal heart morphology | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | heterozygote | abnormal brain morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Scube1 Scube1em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | small epididymis | 0.0 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | homozygote | abnormal thymus morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | enlarged kidney | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | abnormal testis morphology | 0.0 | ||
Dbn1 Dbn1tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Uterus | heterozygote | abnormal uterus morphology | 0.0 | ||
Dync2h1 Dync2h1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Thymus | homozygote | small thymus | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Cck Ccktm2b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Scml2 Scml2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | hemizygote | small testis | 0.0 | ||
Clspn Clspntm1(KOMP)Vlcg |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | abnormal lymph node morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Female | homozygote | female infertility | 0.0 | ||
Trpc3 Trpc3tm1b(EUCOMM)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Uterus | heterozygote | hydrometra | 0.0 | ||
Ppp4r1 Ppp4r1em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
D1Pas1 D1Pas1tm1(KOMP)Vlcg |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Trf Trfem1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Ddrgk1 Ddrgk1tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Sec24d Sec24dem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Tmed6 Tmed6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | abnormal pancreas morphology | 0.0 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, incomplete penetrance | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | small epididymis | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Uterus | heterozygote | hydrometra | 0.0 | ||
Tmed6 Tmed6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Pancreas | homozygote | small pancreas | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Rlim Rlimem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | heterozygote | abnormal lymph node morphology | 0.0 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | heterozygote | abnormal brain morphology | 0.0 | ||
Slc2a2 Slc2a2tm1b(KOMP)Wtsi |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Wasf2 Wasf2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Katna1 Katna1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | heterozygote | enlarged testis | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Wasf2 Wasf2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Stomach | heterozygote | abnormal stomach morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | abnormal lymph node morphology | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Fertility of Homozygous Knock-out Mice | Gross Findings Male | homozygote | male infertility | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | abnormal lymph node morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Tgm3 Tgm3tm1b(KOMP)Wtsi |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | small liver | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Vps11 Vps11em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Mat2a Mat2atm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Bone | homozygote | abnormal bone structure | 0.0 | ||
Psmf1 Psmf1tm1b(EUCOMM)Hmgu |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Uterus | heterozygote | abnormal uterus morphology | 0.0 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | homozygote | small epididymis | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Wdhd1 Wdhd1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | enlarged lymph nodes | 0.0 | ||
Agtr1a Agtr1aem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Brain | homozygote | abnormal brain morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | homozygote | abnormal liver morphology | 0.0 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | heterozygote | abnormal kidney morphology | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Lrrc30 Lrrc30em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Lymph node | homozygote | enlarged lymph nodes | 0.0 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
Gross Pathology and Tissue Collection | Liver | homozygote | small liver | 0.0 | ||
Ftl2-ps Ftl2-psem1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | homozygote | abnormal heart morphology | 0.0 | ||
Tgfbr2 Tgfbr2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Heart | heterozygote | enlarged heart | 0.0 | ||
Katna1 Katna1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Epididymis | heterozygote | abnormal epididymis morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Liver | heterozygote | abnormal liver morphology | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | abnormal testis morphology | 0.0 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Kidney | homozygote | abnormal kidney morphology | 0.0 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Bone | homozygote | abnormal bone structure | 0.0 | ||
Atp6v1e1 Atp6v1e1em1(IMPC)Rbrc |
Viability Primary Screen | Viability Outcome | homozygote | preweaning lethality, complete penetrance | 0.0 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Testes | homozygote | small testis | 0.0 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Gross Pathology and Tissue Collection | Spleen | homozygote | abnormal spleen morphology | 0.0 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 0.0 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 0.0 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Clinical Chemistry | Iron | homozygote | increased circulating iron level | 5.338947149077553E-43 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Clinical Chemistry | Iron | homozygote | increased circulating iron level | 3.936247386288411E-41 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 7.928804819116556E-36 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI4 | homozygote | decreased prepulse inhibition | 7.357423733571505E-34 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | decreased grip strength | 3.5817477438764215E-31 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery average speed | homozygote | hyperactivity | 1.512550898999667E-30 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 3.9521146986510184E-30 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 4.0275332877251996E-30 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 1.6505782356054237E-29 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Whole arena average speed | homozygote | hyperactivity | 5.8170903596068735E-28 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Distance travelled - total | homozygote | hyperactivity | 5.874625109283012E-28 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
X-ray | Tibia length | homozygote | short tibia | 3.059651255086928E-26 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Whole arena average speed | homozygote | hyperactivity | 2.5234977500299086E-25 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Distance travelled - total | homozygote | hyperactivity | 2.61640214535682E-25 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 4.8804004028287835E-25 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 6.857804507357822E-24 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.370717293619521E-23 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery average speed | homozygote | hyperactivity | 1.4822839981787562E-23 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb and hindlimb grip strength normalised against body weight | homozygote | decreased grip strength | 7.18343934705709E-23 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 1.188607775461728E-22 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Periphery average speed | homozygote | hyperactivity | 2.5356612298541E-22 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 4.266751989093999E-22 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Whole arena average speed | homozygote | hyperactivity | 8.603467988763178E-22 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Distance travelled - total | homozygote | hyperactivity | 8.915750884325037E-22 | ||
Pals2 Pals2em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 1.0896942357391696E-21 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Number of digits | homozygote | abnormal digit morphology | 1.2291041582905276E-21 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Number of digits | heterozygote | abnormal digit morphology | 1.2291041582905276E-21 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Number of center entries | homozygote | hyperactivity | 3.391263200779469E-21 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
X-ray | Tibia length | homozygote | short tibia | 4.355476702338919E-21 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 4.366644448401952E-21 | ||
Pals2 Pals2em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 5.569461590385304E-21 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Center average speed | homozygote | hyperactivity | 1.5591716389706684E-20 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | hyperactivity | 1.5591873101658672E-20 | ||
Hbb-bh2 Hbb-bh2tm1b(EUCOMM)Hmgu |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 1.58539520309316E-20 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb and hindlimb grip strength measurement mean | homozygote | decreased grip strength | 1.592730841098085E-19 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 3.8070532743416195E-19 | ||
Hbb-bh2 Hbb-bh2tm1b(EUCOMM)Hmgu |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 1.7103265075925915E-18 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI3 | homozygote | decreased prepulse inhibition | 3.121865865353985E-18 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | hyperactivity | 3.6446078233356994E-18 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | hyperactivity | 1.775801430632313E-17 | ||
Sst Ssttm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 9.156867543393845E-17 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | decreased grip strength | 1.5473570351870773E-15 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - Global | homozygote | decreased prepulse inhibition | 1.9014843580169184E-15 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 3.481144476955196E-15 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Tremor | homozygote | tremors | 3.481144476955196E-15 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Upper teeth appearance | homozygote | abnormal tooth morphology | 3.481144476955196E-15 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Tremor | homozygote | tremors | 3.481144476955196E-15 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 3.481144476955196E-15 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - number | heterozygote | abnormal digit morphology | 3.481144476955196E-15 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - number | homozygote | abnormal digit morphology | 3.481144476955196E-15 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb nail - number | homozygote | abnormal nail morphology | 3.481144476955196E-15 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Upper teeth appearance | homozygote | abnormal tooth morphology | 3.5437872220858615E-15 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb nail - number | homozygote | abnormal nail morphology | 3.5437872220858615E-15 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - size | heterozygote | abnormal digit morphology | 3.5437872220858615E-15 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb nail - number | heterozygote | abnormal nail morphology | 3.5437872220858615E-15 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - number | heterozygote | abnormal digit morphology | 3.5437872220858615E-15 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | heterozygote | abnormal autopod morphology | 3.5437872220858615E-15 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - number | homozygote | abnormal digit morphology | 3.5437872220858615E-15 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | homozygote | abnormal autopod morphology | 3.5437872220858615E-15 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Center average speed | homozygote | hyperactivity | 7.146705814219546E-15 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 1.2035293788859643E-14 | ||
Kif2c Kif2ctm1.1(KOMP)Vlcg |
Combined SHIRPA and Dysmorphology | Skin color - front paws | heterozygote | abnormal skin coloration | 1.344848609915756E-14 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Center distance travelled | homozygote | hyperactivity | 2.042810365310288E-14 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 5.750040471975276E-14 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Center average speed | homozygote | hyperactivity | 9.741381014555586E-14 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | homozygote | hyperactivity | 1.7480651258103275E-13 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - size | heterozygote | abnormal digit morphology | 1.969333170929316E-13 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb nail - number | heterozygote | abnormal nail morphology | 1.969333170929316E-13 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 3.7903239032653635E-13 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 4.079497427800921E-13 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb digit - size | homozygote | abnormal digit morphology | 1.3576463087430768E-12 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | homozygote | abnormal autopod morphology | 1.3576463087430768E-12 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - size | heterozygote | abnormal autopod morphology | 1.3576463087430768E-12 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | heterozygote | abnormal autopod morphology | 1.3576463087430768E-12 | ||
Sst Ssttm1b(KOMP)Wtsi |
Clinical Chemistry | Albumin | homozygote | increased circulating serum albumin level | 3.0247865843990862E-12 | ||
Kif2c Kif2ctm1.1(KOMP)Vlcg |
Combined SHIRPA and Dysmorphology | Skin color - front paws | heterozygote | abnormal skin coloration | 4.237994937622558E-12 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 4.385392656652831E-12 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Center average speed | homozygote | hyperactivity | 6.40896754069975E-12 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 6.832280834839777E-12 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 1.211591677680035E-11 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 1.211591677680035E-11 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 1.211591677680035E-11 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 1.462368594273844E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Corneal opacity | homozygote | corneal opacity | 3.4885670741058306E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | decreased grip strength | 3.641558929401434E-11 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 3.835800080342899E-11 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 4.714183210463574E-11 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Distance travelled - total | homozygote | hyperactivity | 6.929966323010461E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Sacral processes | homozygote | abnormal vertebral arch morphology | 6.972986077435905E-11 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Zygomatic bone | heterozygote | abnormal zygomatic bone morphology | 6.972986077435905E-11 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Zygomatic bone | heterozygote | abnormal zygomatic bone morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Fibula | homozygote | abnormal fibula morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Femur | homozygote | abnormal femur morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Mandibles | homozygote | abnormal mandible morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Humerus | homozygote | abnormal humerus morphology | 6.972986077435905E-11 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Clavicle | heterozygote | abnormal clavicle morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Clavicle | homozygote | abnormal clavicle morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Ulna | homozygote | abnormal ulna morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Zygomatic bone | homozygote | abnormal zygomatic bone morphology | 6.972986077435905E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Syndactylism | homozygote | syndactyly | 6.972986077435905E-11 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Whole arena average speed | homozygote | hyperactivity | 6.982554812129393E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Syndactylism | homozygote | syndactyly | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Femur | homozygote | abnormal femur morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Zygomatic bone | homozygote | abnormal zygomatic bone morphology | 7.09885206173766E-11 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Zygomatic bone | heterozygote | abnormal zygomatic bone morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Tibia | homozygote | abnormal tibia morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Sacral processes | homozygote | abnormal vertebral arch morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Lumbar processes | homozygote | abnormal vertebral arch morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Clavicle | homozygote | abnormal clavicle morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Fibula | homozygote | abnormal fibula morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Humerus | homozygote | abnormal humerus morphology | 7.09885206173766E-11 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Zygomatic bone | heterozygote | abnormal zygomatic bone morphology | 7.09885206173766E-11 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Clavicle | heterozygote | abnormal clavicle morphology | 7.09885206173766E-11 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 7.192049733539818E-11 | ||
Hbb-bh2 Hbb-bh2tm1b(EUCOMM)Hmgu |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 1.5207592130028758E-10 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Periphery average speed | homozygote | hyperactivity | 1.6147592984960824E-10 | ||
Ikzf5 Ikzf5tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.099179302605947E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 2.1426278806746524E-10 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindlimb digit - shape | homozygote | abnormal digit morphology | 2.4534729803349364E-10 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Tail - morphology | homozygote | abnormal tail morphology | 2.4534729803349364E-10 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Forelimb digit - size | homozygote | abnormal digit morphology | 2.4534729803349364E-10 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | homozygote | abnormal autopod morphology | 2.4534729803349364E-10 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Number of center entries | homozygote | hyperactivity | 2.47617565340974E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forepaw - shape | homozygote | abnormal autopod morphology | 2.688139710826931E-10 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindpaw - size | heterozygote | abnormal autopod morphology | 2.688139710826931E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forelimb digit - number | homozygote | abnormal digit morphology | 2.688139710826931E-10 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Hematology | Platelet count | heterozygote | thrombocytopenia | 2.792811537588591E-10 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Whole arena average speed | hemizygote | hyperactivity | 3.9288242104085214E-10 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Distance travelled - total | hemizygote | hyperactivity | 3.9796779760514767E-10 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Skull shape | heterozygote | abnormal cranium morphology | 4.183791646461543E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Tibia | homozygote | abnormal tibia morphology | 4.183791646461543E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Skull shape | homozygote | abnormal cranium morphology | 4.183791646461543E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Radius | homozygote | abnormal radius morphology | 4.183791646461543E-10 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Skull shape | heterozygote | abnormal cranium morphology | 4.183791646461543E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Mandibles | homozygote | abnormal mandible morphology | 4.2593112370425956E-10 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 4.326922431463487E-10 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 4.657974006505583E-10 | ||
Sec24d Sec24dem1(IMPC)Rbrc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | heterozygote | impaired glucose tolerance | 5.786957579800855E-10 | ||
Sst Ssttm1b(KOMP)Wtsi |
Clinical Chemistry | Iron | homozygote | increased circulating iron level | 6.460386114959249E-10 | ||
Fam135b Fam135bem1(IMPC)Rbrc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI3 | homozygote | decreased prepulse inhibition | 7.551204106448495E-10 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Ulna | homozygote | abnormal ulna morphology | 1.490758960720484E-9 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Radius | homozygote | abnormal radius morphology | 1.490758960720484E-9 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Center distance travelled | homozygote | decreased locomotor activity | 1.6832759630602823E-9 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 1.6984739170666785E-9 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - back | homozygote | abnormal coat/hair pigmentation | 1.708344243844806E-9 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - head | homozygote | abnormal coat/hair pigmentation | 1.708344243844806E-9 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Combined SHIRPA and Dysmorphology | Coat - color - abdomen | homozygote | abnormal coat/hair pigmentation | 1.708344243844806E-9 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI1 | homozygote | decreased prepulse inhibition | 1.956704354100225E-9 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 2.796253006920324E-9 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 2.9356581610073818E-9 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 2.9595021988626513E-9 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Corneal opacity | homozygote | corneal opacity | 3.525364444811885E-9 | ||
Sst Ssttm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 4.213217774662326E-9 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 4.403577502642975E-9 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | decreased startle reflex | 4.90822849030792E-9 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 5.352833731819828E-9 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Periphery average speed | hemizygote | hyperactivity | 5.777637479553732E-9 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Tail - morphology | homozygote | abnormal tail morphology | 6.797029161731416E-9 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Periphery permanence time | homozygote | increased thigmotaxis | 7.673349067260915E-9 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Center permanence time | homozygote | increased thigmotaxis | 7.673349067260915E-9 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Percentage center time | homozygote | abnormal behavior | 7.673349067260915E-9 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Skull shape | homozygote | abnormal cranium morphology | 8.9445535422783E-9 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Skull shape | heterozygote | abnormal cranium morphology | 8.9445535422783E-9 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Skull shape | heterozygote | abnormal cranium morphology | 8.9445535422783E-9 | ||
Ikzf5 Ikzf5tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 1.0308155218297088E-8 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Whole arena resting time | homozygote | hyperactivity | 1.0497101854411994E-8 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Clinical Chemistry | Total bilirubin | homozygote | increased circulating bilirubin level | 1.2299618212807673E-8 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 1.231736668216854E-8 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 1.2464050236360436E-8 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | decreased total body fat amount | 1.332421195598954E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
X-ray | Brachydactyly | homozygote | brachydactyly | 1.4331498654485131E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
X-ray | Brachydactyly | homozygote | brachydactyly | 1.4331498654485131E-8 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 1.5953435905657898E-8 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 1.676742655831731E-8 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Lumbar processes | homozygote | abnormal vertebral arch morphology | 1.9384900795671456E-8 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Humerus | heterozygote | abnormal humerus morphology | 1.9663820793880404E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Tail - length | homozygote | abnormal tail length | 1.9995805899952757E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Tail - length | homozygote | abnormal tail length | 1.9995805899952757E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindlimb digit - size | homozygote | abnormal digit morphology | 1.9995805899952757E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindlimb digit - shape | homozygote | abnormal digit morphology | 1.9995805899952757E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Forelimb digit - size | homozygote | abnormal digit morphology | 1.9995805899952757E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindpaw - shape | homozygote | abnormal autopod morphology | 1.9995805899952757E-8 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 2.836451251653216E-8 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery resting time | homozygote | hyperactivity | 2.9666482603829536E-8 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 3.198864462206075E-8 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Number of center entries | homozygote | decreased locomotor activity | 3.266126924472701E-8 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forepaw - shape | homozygote | abnormal autopod morphology | 3.468152698360427E-8 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | hemizygote | increased bone mineral density | 3.5615265403521335E-8 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 3.620668920234493E-8 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | HDL-cholesterol | heterozygote | decreased circulating HDL cholesterol level | 5.763299171235303E-8 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 5.797323154865808E-8 | ||
Runx2 Runx2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 5.952157522415291E-8 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Genitalia - presence | heterozygote | absent external male genitalia | 6.183559264627547E-8 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Genitalia - morphology | heterozygote | abnormal male genitalia morphology | 6.183559264627547E-8 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Genitalia - size | heterozygote | abnormal male genitalia morphology | 6.183559264627547E-8 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Center distance travelled | homozygote | decreased locomotor activity | 7.742250573983256E-8 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | decreased hematocrit | 7.929900647241084E-8 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 8.50905763627452E-8 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 8.58723083752011E-8 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Shape of ribs | homozygote | abnormal rib morphology | 8.974232912350999E-8 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Whole arena resting time | homozygote | hyperactivity | 9.361468755741953E-8 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Tibia length | homozygote | short tibia | 1.0343384104771758E-7 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 1.0518441939666445E-7 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength measurement mean | homozygote | decreased grip strength | 1.3656722330779303E-7 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 1.4667533321244264E-7 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Number of center entries | homozygote | decreased locomotor activity | 1.4989402075116232E-7 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Center average speed | homozygote | hyperactivity | 1.6736504448999767E-7 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Mean corpuscular hemoglobin | homozygote | increased mean corpuscular hemoglobin | 1.732647945118515E-7 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | heterozygote | improved glucose tolerance | 1.912856930630369E-7 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.97777069388394E-7 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 2.0710500336917903E-7 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.2708948677063745E-7 | ||
Hbb-bh2 Hbb-bh2tm1b(EUCOMM)Hmgu |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 2.519109330023639E-7 | ||
Sst Ssttm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 2.533406302518415E-7 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Fusion of vertebrae | homozygote | vertebral fusion | 2.596655690467742E-7 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.735929172104079E-7 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Number of center entries | homozygote | hyperactivity | 2.9008921842432756E-7 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Pelvis | homozygote | abnormal pelvic girdle bone morphology | 2.956110449758853E-7 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 3.2975182762129407E-7 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | White blood cell count | homozygote | decreased leukocyte cell number | 3.4201752896478865E-7 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Lymphocyte cell count | homozygote | decreased lymphocyte cell number | 3.7570180211332627E-7 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Neutrophil differential count | homozygote | increased neutrophil cell number | 3.758406705856032E-7 | ||
Slc5a10 Slc5a10em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength normalised against body weight | homozygote | increased grip strength | 3.86764156701247E-7 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | Albumin | heterozygote | decreased circulating serum albumin level | 4.339315466950211E-7 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Center resting time | homozygote | hyperactivity | 4.567506834973756E-7 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 4.795552399627923E-7 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 5.647904117722646E-7 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Hematology | Mean cell hemoglobin concentration | homozygote | decreased mean corpuscular hemoglobin concentration | 6.176693432280445E-7 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Clinical Chemistry | Triglycerides | heterozygote | decreased circulating triglyceride level | 7.170585831772769E-7 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | increased lean body mass | 7.810724014234438E-7 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | increased lean body mass | 8.73377132393216E-7 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Joints | homozygote | abnormal joint morphology | 8.777869311415998E-7 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Open Field | Center distance travelled | homozygote | hyperactivity | 9.222936796504655E-7 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Optic Disc | homozygote | abnormal optic disk morphology | 1.007172727440775E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 1.0274119404130033E-6 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | decreased total body fat amount | 1.0436762067911332E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Mean cell volume | homozygote | increased mean corpuscular volume | 1.0792321063490817E-6 | ||
Nxn Nxntm1b(EUCOMM)Wtsi |
X-ray | Tibia length | heterozygote | short tibia | 1.208957996823301E-6 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Distance travelled - total | homozygote | hyperactivity | 1.2364689609967172E-6 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Whole arena average speed | homozygote | hyperactivity | 1.2394463055898086E-6 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.283589313061384E-6 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 1.3779359733234742E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | Click-evoked ABR threshold | homozygote | abnormal auditory brainstem response | 1.4817693454460823E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 18kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 1.4817693454460823E-6 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | Click-evoked ABR threshold | homozygote | abnormal auditory brainstem response | 1.4817693454460823E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI2 | homozygote | decreased prepulse inhibition | 1.496907771070255E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 24kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 1.506568878539838E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 30kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 1.5577439853586839E-6 | ||
Ikzf5 Ikzf5tm1(KOMP)Wtsi |
Hematology | Large Unstained Cell (LUC) count | homozygote | increased large unstained cell number | 1.5583802905894117E-6 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | heterozygote | decreased bone mineral content | 1.5800474102434237E-6 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Open Field | Periphery average speed | heterozygote | hyperactivity | 1.7085645822589868E-6 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Periphery average speed | homozygote | hyperactivity | 1.772863697624416E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 1.810816684155725E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Center distance travelled | homozygote | hyperactivity | 1.9307365164422663E-6 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 1.938888772201608E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Number of center entries | heterozygote | decreased locomotor activity | 1.95764982890978E-6 | ||
Penk Penktm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Bone Area | homozygote | abnormal bone structure | 2.0089055396965705E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Number of center entries | homozygote | hyperactivity | 2.07262883122894E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Center permanence time | heterozygote | increased thigmotaxis | 2.075526253975113E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Percentage center time | heterozygote | abnormal behavior | 2.075526253975113E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Periphery permanence time | heterozygote | increased thigmotaxis | 2.075526253975113E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Tail - morphology | homozygote | abnormal tail morphology | 2.0988738924643258E-6 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | increased bone mineral content | 2.35563788919535E-6 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | homozygote | abnormal vertebral arch morphology | 2.3886927920102607E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | heterozygote | abnormal vertebral arch morphology | 2.3886927920102607E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | homozygote | abnormal vertebral arch morphology | 2.3886927920102607E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | increased bone mineral content | 2.4240694074251223E-6 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Clinical Chemistry | Glycosilated hemoglobin A1c (HbA1c) | homozygote | increased glycosylated hemoglobin level | 2.4439464141323697E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Caudal processes | homozygote | abnormal vertebral arch morphology | 2.733271003307891E-6 | ||
Ikzf5 Ikzf5tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 2.9645250378962373E-6 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Cervical processes | heterozygote | abnormal vertebral arch morphology | 3.017296194229857E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
X-ray | Cervical processes | homozygote | abnormal vertebral arch morphology | 3.017296194229857E-6 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
X-ray | Cervical processes | homozygote | abnormal vertebral arch morphology | 3.017296194229857E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Cervical processes | heterozygote | abnormal vertebral arch morphology | 3.017296194229857E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Percentage center time | homozygote | abnormal behavior | 3.035468807865982E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Center permanence time | homozygote | increased thigmotaxis | 3.035468807865982E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Periphery permanence time | homozygote | increased thigmotaxis | 3.035468807865982E-6 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 3.27845077663369E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Limb grasp | homozygote | limb grasping | 3.40746009896975E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 3.40746009896975E-6 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Unexpected behaviors | homozygote | abnormal behavior | 3.40746009896975E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Skin texture - back paws | homozygote | abnormal skin morphology | 3.40746009896975E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 3.40746009896975E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forelimb digit - size | homozygote | abnormal digit morphology | 3.40746009896975E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Retinal Blood Vessels Structure | homozygote | abnormal retina blood vessel morphology | 3.421216888455092E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forelimb nail - number | homozygote | abnormal nail morphology | 3.4334714200667804E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Forelimb digit - size | homozygote | abnormal digit morphology | 3.4334714200667804E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Open Field | Center average speed | homozygote | hyperactivity | 3.4874847187893465E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Distance travelled - total | homozygote | decreased locomotor activity | 3.505348786347895E-6 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 3.5223561098973732E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 3.5253301575721707E-6 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 3.5338214274815982E-6 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 3.707263886099099E-6 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 3.7291040371201234E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 3.913155978807481E-6 | ||
Aifm3 Aifm3em1(IMPC)Rbrc |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | homozygote | increased fasting circulating glucose level | 3.954674411943415E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 3.964580173487775E-6 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Lymphocyte differential count | homozygote | decreased lymphocyte cell number | 4.145927505305735E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | increased bone mineral content | 4.185543275525561E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Corneal vascularization | homozygote | corneal vascularization | 4.318609626352554E-6 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Heart Weight | Heart weight | homozygote | decreased heart weight | 4.332144271756988E-6 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 4.4128978515800554E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Hindlimb nail - length | heterozygote | abnormal nail morphology | 4.429677119333064E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 4.600402917276369E-6 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Pelvis | heterozygote | abnormal pelvic girdle bone morphology | 4.669625013775658E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Pelvis | homozygote | abnormal pelvic girdle bone morphology | 4.669625013775658E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Pelvis | heterozygote | abnormal pelvic girdle bone morphology | 4.669625013775658E-6 | ||
Ttc5 Ttc5em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength normalised against body weight | heterozygote | increased grip strength | 4.677333436120534E-6 | ||
Sst Ssttm1b(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | decreased circulating alkaline phosphatase level | 4.8667484406905714E-6 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | increased bone mineral content | 4.922143943986157E-6 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 4.937704034091439E-6 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 5.0300009206694085E-6 | ||
Penk Penktm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 5.067734036856564E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Whole arena average speed | homozygote | hyperactivity | 5.071488430985482E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Distance travelled - total | homozygote | hyperactivity | 5.110182428325061E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Fusion of vertebrae | homozygote | vertebral fusion | 5.2329705795273185E-6 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Periphery resting time | homozygote | hyperactivity | 5.289040018396918E-6 | ||
Sst Ssttm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 5.412754944700282E-6 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Periphery distance travelled | hemizygote | hyperactivity | 5.414885890786536E-6 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 5.576220246439334E-6 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Fusion of processes | homozygote | fusion of vertebral arches | 5.6978879001690075E-6 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Mean cell hemoglobin concentration | homozygote | increased mean corpuscular hemoglobin concentration | 5.7747820392251015E-6 | ||
Kif2c Kif2ctm1.1(KOMP)Vlcg |
Combined SHIRPA and Dysmorphology | Skin color - back paws | heterozygote | abnormal skin coloration | 6.005927843943937E-6 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Gait | homozygote | abnormal gait | 6.005927843943937E-6 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Hematology | Platelet count | homozygote | thrombocytopenia | 6.126791959104594E-6 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Periphery distance travelled | homozygote | hyperactivity | 6.16895249549998E-6 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | increased bone mineral content | 6.204753390193218E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 6.509230843221303E-6 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
X-ray | Tibia length | heterozygote | short tibia | 6.677754299744265E-6 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Pelvis | homozygote | abnormal pelvic girdle bone morphology | 6.80774837746867E-6 | ||
Dbn1 Dbn1tm1b(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Locomotor activity | heterozygote | increased exploration in new environment | 6.864087481517345E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 12kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 7.0631008384225424E-6 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 12kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 7.0631008384225424E-6 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Periphery distance travelled | homozygote | decreased locomotor activity | 7.0772794060758315E-6 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | Total protein | heterozygote | decreased circulating total protein level | 7.224130968097597E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | homozygote | improved glucose tolerance | 7.289328550541541E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Periphery average speed | homozygote | decreased locomotor activity | 7.348642157012364E-6 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 7.477812687284313E-6 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Hematology | White blood cell count | homozygote | increased leukocyte cell number | 8.110053386189975E-6 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Open Field | Latency to center entry | homozygote | decreased exploration in new environment | 8.170786713890266E-6 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 8.243774573202245E-6 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | heterozygote | abnormal vertebral arch morphology | 8.28076917969156E-6 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | homozygote | abnormal vertebral arch morphology | 8.28076917969156E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | homozygote | abnormal vertebral arch morphology | 8.28076917969156E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Processes on vertebrae | heterozygote | abnormal vertebral arch morphology | 8.28076917969156E-6 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 8.369566785404459E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Y-maze | Total arm entries | heterozygote | decreased locomotor activity | 8.373172931896988E-6 | ||
Ppp4r1 Ppp4r1em1(IMPC)Rbrc |
Hematology | Platelet count | homozygote | thrombocytosis | 8.444640116067603E-6 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Open Field | Distance travelled - total | heterozygote | hyperactivity | 8.731158231967129E-6 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Open Field | Whole arena average speed | heterozygote | hyperactivity | 8.7548432929907E-6 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Clinical Chemistry | Iron | homozygote | increased circulating iron level | 8.805333891359624E-6 | ||
Penk Penktm1(KOMP)Mbp |
Open Field | Periphery resting time | homozygote | decreased locomotor activity | 9.146600859821774E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Center distance travelled | homozygote | hyperactivity | 9.442601367481984E-6 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Clinical Chemistry | Total bilirubin | heterozygote | increased circulating bilirubin level | 9.669183782534674E-6 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Cervical processes | heterozygote | abnormal vertebral arch morphology | 9.936923561326694E-6 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Cervical processes | heterozygote | abnormal vertebral arch morphology | 9.936923561326694E-6 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
X-ray | Cervical processes | homozygote | abnormal vertebral arch morphology | 9.936923561326694E-6 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
X-ray | Cervical processes | homozygote | abnormal vertebral arch morphology | 9.936923561326694E-6 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Periphery average speed | homozygote | hyperactivity | 9.945680176315363E-6 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Indirect Calorimetry | Total water intake | homozygote | increased fluid intake | 1.0269612175761722E-5 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Center distance travelled | hemizygote | hyperactivity | 1.0557189852988813E-5 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 1.106534637074219E-5 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Hematology | Mean cell volume | homozygote | decreased mean corpuscular volume | 1.1110402738268021E-5 | ||
Slc2a2 Slc2a2tm1b(KOMP)Wtsi |
Clinical Chemistry | Glycosilated hemoglobin A1c (HbA1c) | heterozygote | increased glycosylated hemoglobin level | 1.1186608389834873E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | decreased locomotor activity | 1.133670230046846E-5 | ||
Ppme1 Ppme1em1(IMPC)Rbrc |
Clinical Chemistry | Triglycerides | heterozygote | increased circulating triglyceride level | 1.1679996532620862E-5 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Platelet count | homozygote | thrombocytopenia | 1.2131402399973013E-5 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
Auditory Brain Stem Response | 6kHz-evoked ABR Threshold | homozygote | abnormal auditory brainstem response | 1.2842001524404623E-5 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI4 | heterozygote | decreased prepulse inhibition | 1.327909376414027E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Hematology | Large Unstained Cell (LUC) count | heterozygote | increased large unstained cell number | 1.348152454738738E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Combined SHIRPA and Dysmorphology | Skin texture - back paws | homozygote | abnormal skin morphology | 1.3628779015562031E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.3851570656697731E-5 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat/Body weight | heterozygote | decreased total body fat amount | 1.386034728056984E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.4304384421848226E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 1.500848065916216E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | decreased total body fat amount | 1.619533031771425E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.626483935979195E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Electrocardiogram (ECG) | ST | homozygote | prolonged ST segment | 1.6499674529768527E-5 | ||
Oxtr Oxtrtm1.1(KOMP)Vlcg |
Clinical Chemistry | LDL-cholesterol | homozygote | increased circulating LDL cholesterol level | 1.699115091469139E-5 | ||
Diaph1 Diaph1em1(IMPC)Rbrc |
Clinical Chemistry | Urea (Blood Urea Nitrogen - BUN) | homozygote | increased blood urea nitrogen level | 1.7119627955253236E-5 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Joints | homozygote | abnormal joint morphology | 1.7202264643856324E-5 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Open Field | Periphery resting time | homozygote | hyperactivity | 1.732847886160016E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | heterozygote | improved glucose tolerance | 1.7428741557523608E-5 | ||
Rln3 Rln3tm1(KOMP)Mbp |
Hematology | Red blood cell count | homozygote | decreased erythrocyte cell number | 1.8033924789051525E-5 | ||
Trf Trfem1(IMPC)Rbrc |
Clinical Chemistry | Iron | heterozygote | decreased circulating iron level | 1.8281252778251655E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Hematology | Lymphocyte cell count | homozygote | increased lymphocyte cell number | 1.8488204659661278E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 1.8567443476058543E-5 | ||
Wdhd1 Wdhd1em1(IMPC)Rbrc |
Clinical Chemistry | Aspartate aminotransferase | heterozygote | increased circulating aspartate transaminase level | 1.903011798276566E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Clinical Chemistry | Alpha-amylase | homozygote | decreased circulating amylase level | 1.9307519323774613E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 1.977075226022862E-5 | ||
Unc5c Unc5cem2(IMPC)Rbrc |
Open Field | Whole arena resting time | heterozygote | decreased locomotor activity | 2.205182499892544E-5 | ||
Sst Ssttm1b(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | decreased circulating alkaline phosphatase level | 2.213092739111744E-5 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Pelvis | heterozygote | abnormal pelvic girdle bone morphology | 2.2636542780674063E-5 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Pelvis | heterozygote | abnormal pelvic girdle bone morphology | 2.2636542780674063E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
X-ray | Pelvis | homozygote | abnormal pelvic girdle bone morphology | 2.2636542780674063E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Clinical Chemistry | Total cholesterol | homozygote | increased circulating cholesterol level | 2.2763570086681284E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 2.283134926983621E-5 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Periphery resting time | homozygote | hyperactivity | 2.288144787598867E-5 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Number of center entries | hemizygote | hyperactivity | 2.375525946263224E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 2.4991231839521788E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Hematology | Platelet count | heterozygote | thrombocytopenia | 2.516020686016418E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | Total cholesterol | heterozygote | decreased circulating cholesterol level | 2.5290641133324243E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | Uric acid | heterozygote | increased blood uric acid level | 2.5913801437127404E-5 | ||
Ikzf4 Ikzf4em1(IMPC)Rbrc |
Open Field | Center resting time | homozygote | decreased locomotor activity | 2.640918319229968E-5 | ||
Gypc Gypcem1(IMPC)Rbrc |
Clinical Chemistry | Glycosilated hemoglobin A1c (HbA1c) | homozygote | decreased glycosylated hemoglobin level | 2.6432351660332642E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.6436384359840304E-5 | ||
Tfr2 Tfr2em1(IMPC)Rbrc |
Hematology | Hemoglobin | homozygote | increased hemoglobin content | 2.6712972612585872E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 2.8047867090208456E-5 | ||
Kif2c Kif2ctm1.1(KOMP)Vlcg |
Clinical Chemistry | Triglycerides | heterozygote | increased circulating triglyceride level | 2.8491362172644585E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 2.8658436349360272E-5 | ||
Trf Trfem1(IMPC)Rbrc |
Clinical Chemistry | Iron | heterozygote | decreased circulating iron level | 2.9948432711535133E-5 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 3.0456591048277915E-5 | ||
Shank2 Shank2em2(IMPC)Rbrc |
Open Field | Center resting time | homozygote | hyperactivity | 3.108620876446366E-5 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | increased bone mineral content | 3.117442611255683E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Body Composition (DEXA lean/fat) | Lean mass | homozygote | decreased lean body mass | 3.139554974040948E-5 | ||
Runx2 Runx2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Area | heterozygote | abnormal bone structure | 3.171585558447987E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
X-ray | Tibia length | homozygote | short tibia | 3.3069922210415825E-5 | ||
Ikzf3 Ikzf3tm1(KOMP)Vlcg |
Hematology | Large Unstained Cell (LUC) count | homozygote | decreased large unstained cell number | 3.3246225939365104E-5 | ||
Dbn1 Dbn1tm1b(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | heterozygote | increased circulating alkaline phosphatase level | 3.325464058434591E-5 | ||
Atp6v1g2 Atp6v1g2em1(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | hyperactivity | 3.345571531099267E-5 | ||
Ube2g1 Ube2g1tm1b(EUCOMM)Hmgu |
X-ray | Tibia length | homozygote | short tibia | 3.4198787034256384E-5 | ||
Tmem63c Tmem63cem1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 3.425738759688102E-5 | ||
Rlim Rlimem1(IMPC)Rbrc |
X-ray | Fusion of processes | hemizygote | fusion of vertebral arches | 3.454784018686041E-5 | ||
Hbq1a Hbq1atm1.1(KOMP)Vlcg |
Hematology | Red blood cell count | homozygote | increased erythrocyte cell number | 3.519946039887145E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Indirect Calorimetry | Respiratory Exchange Ratio | homozygote | decreased respiratory quotient | 3.6441000702325255E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Open Field | Whole arena resting time | homozygote | hyperactivity | 3.6782646930078045E-5 | ||
Pomc Pomcem1(IMPC)Rbrc |
Intraperitoneal glucose tolerance test (IPGTT) | Area under glucose response curve | heterozygote | impaired glucose tolerance | 3.6982251913286746E-5 | ||
Fam135b Fam135bem1(IMPC)Rbrc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - Global | homozygote | decreased prepulse inhibition | 3.724996349774301E-5 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Clinical Chemistry | Alkaline phosphatase | homozygote | increased circulating alkaline phosphatase level | 3.7943493225611746E-5 | ||
Tecr Tecrem1(IMPC)Rbrc |
Clinical Chemistry | LDL-cholesterol | heterozygote | increased circulating LDL cholesterol level | 3.8024780224077404E-5 | ||
Ttc5 Ttc5em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength measurement mean | heterozygote | increased grip strength | 3.9323138480540365E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 3.936115535907447E-5 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Hematology | Large Unstained Cell (LUC) differential count | homozygote | decreased large unstained cell number | 3.987849413533695E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | decreased bone mineral density | 4.002551213488914E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
X-ray | Tibia length | homozygote | short tibia | 4.0311588236363605E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Center average speed | homozygote | hyperactivity | 4.052327130921185E-5 | ||
Ptprm Ptprmem1(IMPC)Rbrc |
Clinical Chemistry | Creatine kinase | homozygote | increased circulating creatine kinase level | 4.1237217374145985E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 4.2313829908380285E-5 | ||
Ppp4r1 Ppp4r1em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | homozygote | increased bone mineral density | 4.262800939613953E-5 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat/Body weight | homozygote | increased total body fat amount | 4.296024053473957E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Clinical Chemistry | Lactate dehydrogenase | homozygote | increased circulating lactate dehydrogenase level | 4.3025356717407703E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI1 | homozygote | increased prepulse inhibition | 4.333898687036708E-5 | ||
Runx2 Runx2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Lean/Body weight | heterozygote | increased lean body mass | 4.393661947688088E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - Global | homozygote | increased prepulse inhibition | 4.419680408318527E-5 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | decreased bone mineral content | 4.4505544792627916E-5 | ||
Pals2 Pals2em1(IMPC)Rbrc |
X-ray | Fusion of processes | homozygote | fusion of vertebral arches | 4.4901767978444695E-5 | ||
Wdhd1 Wdhd1em1(IMPC)Rbrc |
Clinical Chemistry | Total bilirubin | heterozygote | increased circulating bilirubin level | 4.5039429096505046E-5 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Combined SHIRPA and Dysmorphology | Hindlimb digit - size | homozygote | abnormal digit morphology | 4.5090542698744684E-5 | ||
Twist1 Twist1em1(IMPC)Rbrc |
Grip Strength | Forelimb grip strength normalised against body weight | heterozygote | increased grip strength | 4.528945282800123E-5 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
X-ray | Tibia length | homozygote | short tibia | 4.652858478948474E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Bone Mineral Density (excluding skull) | heterozygote | decreased bone mineral density | 4.748718492919579E-5 | ||
Penk Penktm1(KOMP)Mbp |
Eye Morphology | Retina (combined) | homozygote | abnormal retina morphology | 4.771541352965869E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Indirect Calorimetry | Respiratory Exchange Ratio | homozygote | decreased respiratory quotient | 4.851210906053893E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Hematology | Platelet count | heterozygote | thrombocytopenia | 4.884684312855825E-5 | ||
Ikzf4 Ikzf4em1(IMPC)Rbrc |
Open Field | Periphery permanence time | homozygote | decreased thigmotaxis | 4.9221780500374734E-5 | ||
Ikzf4 Ikzf4em1(IMPC)Rbrc |
Open Field | Center permanence time | homozygote | decreased thigmotaxis | 4.9221780500374734E-5 | ||
Ikzf4 Ikzf4em1(IMPC)Rbrc |
Open Field | Percentage center time | homozygote | abnormal behavior | 4.9221780500374734E-5 | ||
Stx7 Stx7em1(IMPC)Rbrc |
Hematology | Large Unstained Cell (LUC) count | homozygote | decreased large unstained cell number | 4.9848655180539936E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Hematology | Hematocrit | homozygote | increased hematocrit | 5.169091673451476E-5 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Center resting time | heterozygote | hyperactivity | 5.189068542676978E-5 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 5.2543186029652134E-5 | ||
Cnot3 Cnot3em1(IMPC)Rbrc |
Open Field | Center distance travelled | heterozygote | decreased locomotor activity | 5.374754255171865E-5 | ||
Nin Nintm1b(EUCOMM)Hmgu |
Open Field | Center average speed | homozygote | hyperactivity | 5.509674519998953E-5 | ||
Nlgn3 Nlgn3em1(IMPC)Rbrc |
Open Field | Whole arena resting time | hemizygote | hyperactivity | 5.5278604122577235E-5 | ||
Gal3st1 Gal3st1em1(IMPC)Rbrc |
Open Field | Percentage center movement time | homozygote | increased anxiety-related response | 5.567768312175758E-5 | ||
Tmed6 Tmed6em1(IMPC)Rbrc |
Y-maze | Latency to leave start arm | homozygote | decreased exploration in new environment | 5.586039333138615E-5 | ||
Ppp4r2 Ppp4r2tm2b(EUCOMM)Hmgu |
Combined SHIRPA and Dysmorphology | Locomotor activity | heterozygote | increased exploration in new environment | 5.643313124892302E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Clinical Chemistry | Calcium | heterozygote | decreased circulating calcium level | 5.668835365213454E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Eye Morphology | Pupil Position | homozygote | abnormal placement of pupils | 5.7709428801899776E-5 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | BMC/Body weight | homozygote | decreased bone mineral content | 5.8355421060696244E-5 | ||
Aifm3 Aifm3em1(IMPC)Rbrc |
Clinical Chemistry | Aspartate aminotransferase | homozygote | increased circulating aspartate transaminase level | 6.051471063983627E-5 | ||
Fbn2 Fbn2em1(IMPC)Rbrc |
Open Field | Percentage center movement time | homozygote | decreased anxiety-related response | 6.174235022626817E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Center permanence time | homozygote | decreased thigmotaxis | 6.320057582342997E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Percentage center time | homozygote | abnormal behavior | 6.320057582342997E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Periphery permanence time | homozygote | decreased thigmotaxis | 6.320057582342997E-5 | ||
Penk Penktm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Body length | homozygote | decreased body length | 6.42131781205535E-5 | ||
Fam135b Fam135bem1(IMPC)Rbrc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | % Pre-pulse inhibition - PPI2 | homozygote | decreased prepulse inhibition | 6.571877020178363E-5 | ||
Ube3c Ube3ctm1b(EUCOMM)Hmgu |
Clinical Chemistry | Albumin | homozygote | decreased circulating serum albumin level | 6.989878602325916E-5 | ||
Etv6 Etv6em1(IMPC)Rbrc |
Hematology | Red blood cell count | heterozygote | decreased erythrocyte cell number | 6.993179704295471E-5 | ||
Prkab1 Prkab1tm1b(KOMP)Wtsi |
Clinical Chemistry | Alpha-amylase | homozygote | decreased circulating amylase level | 7.03254045220092E-5 | ||
Pals2 Pals2em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 7.178218947956339E-5 | ||
Ube2j1 Ube2j1tm1.1(NCOM)Mfgc |
Clinical Chemistry | Alpha-amylase | homozygote | increased circulating amylase level | 7.523662497987971E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
X-ray | Tibia length | heterozygote | short tibia | 7.545624976046383E-5 | ||
Sst Ssttm1b(KOMP)Wtsi |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | decreased lean body mass | 7.585869025206193E-5 | ||
Dnase1l2 Dnase1l2tm1(KOMP)Wtsi |
Heart Weight | Heart weight | homozygote | increased heart weight | 7.618608651682734E-5 | ||
Septin5 Septin5tm1b(EUCOMM)Hmgu |
Body Composition (DEXA lean/fat) | Body length | heterozygote | decreased body length | 7.695220847381279E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Lean/Body weight | homozygote | increased lean body mass | 8.137524855555966E-5 | ||
Ftl1 Ftl1em1(IMPC)Rbrc |
Hematology | Red blood cell distribution width | homozygote | increased red blood cell distribution width | 8.345740934601054E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Open Field | Number of center entries | homozygote | hyperactivity | 8.44671594677493E-5 | ||
Penk Penktm1(KOMP)Mbp |
Body Composition (DEXA lean/fat) | Fat mass | homozygote | increased total body fat amount | 8.4793267888017E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Acoustic Startle and Pre-pulse Inhibition (PPI) | Response amplitude - S | homozygote | increased startle reflex | 8.482090925099328E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Whole arena average speed | homozygote | decreased locomotor activity | 8.491763583151624E-5 | ||
Ap4e1 Ap4e1tm1b(KOMP)Wtsi |
Clinical Chemistry | Creatine kinase | homozygote | increased circulating creatine kinase level | 8.503966819262132E-5 | ||
Cadps2 Cadps2em1(IMPC)Rbrc |
Clinical Chemistry | Alpha-amylase | homozygote | increased circulating amylase level | 8.540787530364469E-5 | ||
Cnot7 Cnot7em1(IMPC)Rbrc |
Open Field | Distance travelled - total | homozygote | decreased locomotor activity | 8.626346971141174E-5 | ||
Rnf10 Rnf10tm1b(KOMP)Wtsi |
Hematology | Hemoglobin | homozygote | decreased hemoglobin content | 8.74840043252334E-5 | ||
Twist1 Twist1em1(IMPC)Rbrc |
X-ray | Shape of vertebrae | heterozygote | abnormal vertebrae morphology | 8.786158286966383E-5 | ||
Runx2 Runx2em1(IMPC)Rbrc |
X-ray | Shape of vertebrae | heterozygote | abnormal vertebrae morphology | 8.786158286966383E-5 | ||
Slc2a2 Slc2a2tm1b(KOMP)Wtsi |
Intraperitoneal glucose tolerance test (IPGTT) | Fasted blood glucose concentration | heterozygote | increased fasting circulating glucose level | 9.085791680263355E-5 | ||
Zfhx2 Zfhx2em1(IMPC)Rbrc |
Open Field | Periphery permanence time | homozygote | decreased thigmotaxis | 9.22720500966534E-5 | ||
Ppp4r1 Ppp4r1em1(IMPC)Rbrc |
Body Composition (DEXA lean/fat) | Bone Mineral Content (excluding skull) | homozygote | increased bone mineral content | 9.385932207806036E-5 | ||
Hbq1a Hbq1atm1.1(KOMP)Vlcg |
Hematology | Mean corpuscular hemoglobin | homozygote | decreased mean corpuscular hemoglobin | 9.446012700209394E-5 | ||
Npsr1 Npsr1tm1b(KOMP)Wtsi |
Hematology | Eosinophil cell count | homozygote | increased eosinophil cell number | 9.44971470744349E-5 | ||
Ube2j2 Ube2j2em1(IMPC)Rbrc |
Hematology | Eosinophil differential count | homozygote | increased eosinophil cell number | 9.56714793574065E-5 |